Shiren Sun Selected Research

Peritoneal Dialysis

12/2019	Expression of XBP1s in peritoneal mesothelial cells is critical for inflammation-induced peritoneal fibrosis.
8/2017	The MicroRNA-199a/214 Cluster Targets E-Cadherin and Claudin-2 and Promotes High Glucose-Induced Peritoneal Fibrosis.
1/2014	Serum response factor accelerates the high glucose-induced Epithelial-to-Mesenchymal Transition (EMT) via snail signaling in human peritoneal mesothelial cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shiren Sun Research Topics

Disease

16	Fibrosis (Cirrhosis) 02/2022 - 02/2011
12	Hypoxia (Hypoxemia) 01/2019 - 01/2008
11	Stomach Neoplasms (Stomach Cancer) 01/2012 - 05/2007
8	Hemorrhage 04/2022 - 12/2015
8	Neoplasms (Cancer) 01/2022 - 09/2007
6	Hyperbilirubinemia 02/2022 - 07/2020
6	IGA Glomerulonephritis (IGA Nephropathy) 12/2021 - 11/2012
5	Neoplasm Metastasis (Metastasis) 11/2017 - 02/2009
4	Critical Illness (Critically Ill) 04/2022 - 11/2015
4	Immunoglobulin Light-chain Amyloidosis 01/2021 - 01/2019
4	Hypernatremia 01/2020 - 08/2013
3	Proteinuria 03/2022 - 01/2021
3	Acute Kidney Injury (Acute Renal Failure) 01/2021 - 10/2017
3	Kidney Diseases (Kidney Disease) 01/2019 - 11/2012
2	Hyperlactatemia 04/2022 - 10/2020
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2022 - 01/2014
2	Chronic Renal Insufficiency 01/2021 - 12/2020
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 09/2012
2	Amyloidosis 01/2021 - 01/2019
2	Alkalosis 01/2020 - 01/2019
2	Liver Failure 01/2020 - 01/2019
2	Peritoneal Fibrosis 12/2019 - 08/2017
2	Inflammation (Inflammations) 12/2019 - 01/2019
2	Carcinogenesis 08/2016 - 01/2012
2	Pancreatitis 09/2015 - 04/2014
2	Kidney Neoplasms (Kidney Cancer) 01/2009 - 05/2007
1	Aortic Dissection 12/2021
1	Reperfusion Injury 01/2021
1	Ureteral Obstruction 01/2021
1	Disease Progression 01/2021
1	Hypercalcemia (Milk Alkali Syndrome) 11/2020
1	Hypertension (High Blood Pressure) 10/2020
1	Xerostomia 06/2020
1	Acidosis 01/2020
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2020
1	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 12/2019

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2007
8	Citric Acid (Citrate)FDA LinkGeneric 04/2022 - 12/2015
8	Small Interfering RNA (siRNA)IBA 01/2018 - 09/2007
7	MicroRNAs (MicroRNA)IBA 01/2021 - 07/2008
5	BilirubinIBA 02/2022 - 01/2021
5	Cadherins (E-Cadherin)IBA 01/2018 - 01/2010
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 02/2018
4	CalciumIBA 11/2020 - 06/2007
4	Carrier Proteins (Binding Protein)IBA 08/2016 - 05/2007
4	S100 Calcium Binding Protein A6IBA 08/2016 - 05/2007
4	beta CateninIBA 03/2010 - 05/2007
3	Adrenal Cortex Hormones (Corticosteroids)IBA 08/2021 - 12/2020
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 02/2014
3	Lactic Acid (Lactate)FDA LinkGeneric 10/2020 - 11/2017
3	Pharmaceutical PreparationsIBA 10/2018 - 01/2008
3	CreatinineIBA 02/2018 - 01/2012
2	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 04/2022 - 11/2020
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2021 - 02/2014
2	Amyloid (Amyloid Fibrils)IBA 01/2021 - 01/2019
2	Bortezomib (Velcade)FDA Link 01/2021 - 11/2019
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021 - 01/2019
2	AcidsIBA 01/2019 - 10/2018
2	Celecoxib (Celebrex)FDA Link 01/2018 - 01/2009
2	Glucose (Dextrose)FDA LinkGeneric 08/2017 - 01/2014
2	Serum Response FactorIBA 08/2017 - 01/2014
2	SodiumIBA 01/2016 - 08/2013
2	CyclinsIBA 08/2015 - 01/2012
2	Messenger RNA (mRNA)IBA 09/2014 - 01/2014
2	S100 Proteins (S 100 Protein)IBA 01/2012 - 06/2007
2	Biological ProductsIBA 01/2012 - 06/2007
2	Cyclin D1IBA 04/2009 - 02/2009
2	Vincristine (Oncovin)FDA LinkGeneric 01/2008 - 09/2007
1	SteroidsIBA 03/2022
1	Galectin 3 (LGALS3)IBA 02/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2022
1	Uremic ToxinsIBA 01/2022
1	PrebioticsIBA 01/2022
1	Contrast MediaIBA 12/2021
1	Immunosuppressive Agents (Immunosuppressants)IBA 08/2021
1	Alkaline PhosphataseIBA 07/2021
1	Alanine Transaminase (SGPT)IBA 07/2021
1	Competitive Endogenous RNAIBA 01/2021
1	Circular RNAIBA 01/2021
1	Thalidomide (Thalomid)FDA Link 01/2021
1	Syntex adjuvant formulationIBA 01/2021
1	HMGB1 Protein (HMG1)IBA 06/2020
1	Lipocalin-2IBA 01/2020
1	STF 083010IBA 12/2019
1	chlorhexidine gluconate (Dyna-Hex)FDA LinkGeneric 12/2019

Therapy/Procedure

15	Continuous Renal Replacement Therapy 04/2022 - 08/2013
6	Therapeutics 11/2019 - 09/2007
4	Contraindications 04/2022 - 12/2015
3	Cardiopulmonary Bypass (Heart-Lung Bypass) 07/2021 - 01/2021
3	Peritoneal Dialysis 12/2019 - 01/2014
2	Length of Stay 12/2021 - 06/2017
2	Renal Replacement Therapy (Therapies, Renal Replacement) 12/2021 - 10/2017
2	Catheters 11/2020 - 01/2020
2	Hemoperfusion 06/2017 - 09/2015
2	Hemofiltration 09/2015 - 04/2014
2	Continuous Ambulatory Peritoneal Dialysis (CAPD) 08/2015 - 09/2012
1	Precision Medicine 01/2022
1	Endovascular Aneurysm Repair 12/2021
1	Fecal Microbiota Transplantation 12/2021
1	Blood Transfusion (Blood Transfusions) 07/2020